News

Atrial fib linked to incident myocardial infarction

View on the News

Look for links with other conditions

Jonathan W. Dukes, M.D., and Gregory M. Marcus, M.D., commented: These findings "add to the growing recognition of important bidirectional relationships between AF and other cardiovascular comorbidities," with AF appearing to lead to kidney disease, heart failure, and now MI, said Dr. Jonathan W. Dukes and Dr. Gregory M. Marcus.

They do not suggest a change in contemporary AF treatment, but rather a "change in management may be most applicable to patients with MI. For example, we now know that a large proportion of strokes are due to subclinical AF. Perhaps the same is true for MI?"

"Our regular clinical practice must extend beyond the common question, ‘Why does this patient have AF?’ to ‘Could this current problem have occurred due to AF?’ " they said.

Jonathan W. Dukes, M.D., and Gregory M. Marcus, M.D., are in the division of cardiology and section of electrophysiology at the University of California, San Francisco. They reported no financial conflicts of interest. These remarks were taken from their editorial accompanying Dr. Soliman’s report (JAMA Intern. Med. 2013 Nov. 4 [doi: 10.1001/jamainternmed.2013.11392]).


 

FROM JAMA INTERNAL MEDICINE

Atrial fibrillation is strongly associated with incident myocardial infarction, independently of coronary risk factors and potential confounders, according to an analysis of data from the REGARDS study published online Nov. 4 in JAMA.

In a cohort study involving nearly 24,000 adults in the general population, those who had AF at baseline were twice as likely to develop MI during the ensuing 7 years of follow-up as were those without AF. The increased risk conferred by AF was significantly stronger among women and blacks than among men and whites, reported Dr. Elsayed Z. Soliman of the Epidemiological Cardiology Research Center, Wake Forest University, Winston-Salem, N.C., and his associates.

"These findings add to the growing concerns of the seriousness of AF as a public health burden: In addition to being a well-known risk factor for stroke, it is also associated with increased risk of MI," they said.

This is the first report of such an association, the investigators noted.

MI is known to be a risk factor for AF, and recent research has suggested that the converse may also be true. But to date there has been little evidence from population studies to support this assertion.

Dr. Soliman and his colleagues examined the issue in a secondary analysis of data from the REGARDS (Reasons for Geographic and Racial Differences in Stroke) study, a large biracial, population-based cohort study of the causes of regional and racial disparities in stroke mortality. REGARDS assessed more than 30,000 adults residing in the "stroke belt" of the southeastern United States, carefully characterizing their cardiovascular risk and rigorously adjudicating incident MIs during up to 7 years of close follow-up (median follow-up, 4.5 years).

For their analysis, Dr. Soliman and his associates studied the records of a subset of 23,928 participants who had no coronary heart disease (CHD) at baseline and whose atrial fibrillation status was known. There were 1,631 study subjects who had already been diagnosed as having AF or who were found to have AF on baseline ECG.

A total of 648 MIs occurred during follow-up.

The age-adjusted incidence of MI was 12 per 1,000 in participants who had AF, compared with 6 per 1,000 in participants who didn\'t have AF, the researchers reported (JAMA Intern. Med. 2013 Nov. 4 [doi: 10.1001/jamainternmed.2013.11912]).

In a further analysis that adjusted for numerous sociodemographic factors, AF was associated with a 96% increase in MI risk, compared with no AF.

The association between AF and incident MI remained strong after further adjustment for CHD risk factors and numerous potential confounders.

These results indicate a bidirectional relationship between AF and MI, "with each leading to the other. Similar bidirectional relationships between AF and chronic kidney disease and between AF and heart failure have been reported," the researchers said.

In subgroup analyses, this association remained robust regardless of subject age, and was no different between older adults (those over age 65 or 75) and younger adults. However, the association was different according to subject gender and race: It was strongest among black men, less strong but still significant among white women, even less strong but still significant among black women, and nonsignificant among white men.

In addition, the association between AF and incident MI was significantly weaker among participants who were taking warfarin than among those who were not. "This accords with previous reports showing that warfarin might provide a protective effect against MI after acute coronary syndromes and in patients with AF who are prescribed anticoagulation for stroke prevention," the investigators said.

Although this study was not designed to determine why AF appears to raise the risk of incident MI, there are several plausible explanations.

First, both conditions share similar risk factors, so common pathophysiologic processes might underlie both outcomes. "That is, in susceptible individuals, both AF and MI may eventually occur, and it is just a matter of which comes first," Dr. Soliman and his associates said.

Second, subclinical CHD may be associated with a high risk of both AF and MI. Thus, "AF may not be a risk factor for incident MI but rather a marker of prevalent CHD that in turn places individuals at higher risk for MI events," they said.

A third possibility is that AF "creates and sustains an inflammatory and prothrombotic environment," including systemic platelet activation, thrombin generation, endothelial dysfunction, and inflammation, which in turn increase the risk of MI.

Finally, reports have suggested that MI due to coronary embolism actually is more frequent than it is thought to be, and have identified AF as an underlying cause of such emboli. So "coronary embolization, which may not be as rare as we think, could be one of the mechanisms explaining our findings," the investigators said.

Pages

Recommended Reading

CLARIFY'ed: Angina's impact on outcomes in stable CAD
MDedge Cardiology
Even low arsenic exposure linked to cardiovascular disease
MDedge Cardiology
Think exercise first for secondary prevention?
MDedge Cardiology
75% of increase in MI spending came after 30 days
MDedge Cardiology
Gender-specific biomarker thresholds urged in MI diagnosis
MDedge Cardiology
Hunting for cardiovascular signals from diabetes drugs
MDedge Cardiology
Flu vaccine linked to lower cardiovascular risk
MDedge Cardiology
Novel two-biomarker strategy permits early ACS rule-out
MDedge Cardiology
Prehospital bivalirudin reduced bleeding with PCI
MDedge Cardiology
Shorter antiplatelet therapy after stenting found noninferior
MDedge Cardiology